BeiGene Ltd (BGNE)
176.50
+1.78
(+1.02%)
USD |
NASDAQ |
Dec 20, 16:00
177.10
+0.60
(+0.34%)
After-Hours: 20:00
BeiGene Profit Margin (Quarterly): -12.12% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Theravance Biopharma Inc | -75.28% |
| Merck & Co Inc | 18.95% |
| Dr Reddy's Laboratories Ltd | 15.66% |
| Bristol-Myers Squibb Co | 10.18% |
| Zai Lab Ltd | -40.75% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.64% |
| Return on Assets | -15.07% |
| Return on Invested Capital | -19.56% |
| Gross Profit Margin (Quarterly) | 82.98% |
| Operating Margin (Quarterly) | -12.01% |
| Return on Net Operating Assets | -32.56% |